NCT06665438View on ClinicalTrials.gov

Dexmedetomidine and Bupivacaine Intra-articular for Postoperative Analgesia After Knee Arthroscopic Surgery

PHASE3RecruitingINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions
Post Operative Analgesia
Interventions
DRUG

Normal Saline (Placebo)

the 18 ml of normal saline will injected intra articular in the knee joint by the surgeon through the arthroscope after completing the procedure

DRUG

Bupivacaine 0.25%

the 18ml 0.25% bupivacaine. will injected intra articular in the knee joint by the surgeon through the arthroscope after completing the procedure

DRUG

Dexmedetomidine

Dexmedetomidine 1 μg/kg will injected intra articular in the knee joint by the surgeon through the arthroscope after completing the procedure.

Trial Locations (2)

71523

RECRUITING

Al-Azhar University, Asyut

Unknown

NOT_YET_RECRUITING

Al-Azhar University, Asyut

All Listed Sponsors
lead

Al-Azhar University

OTHER